Highland Capital Management (Texas)’s AbbVie ABBV Stock Holding History

Highland Capital Management (Texas)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.09M	Buy	15,000 +10,000	+200%	+$786K	0.06%	202
2019 Q1	$403K	Buy	+5,000	New	+$409K	0.03%	258
2018 Q1	–	Sell	-10,750	Closed	-$1.04M	–	326
2017 Q4	$1.04M	Sell	10,750 -23,250	-68%	-$2.19M	0.05%	168
2017 Q3	$3.02M	Sell	34,000 -70,000	-67%	-$5.33M	0.13%	131
2017 Q2	$7.54M	Buy	104,000 +44,000	+73%	+$2.96M	0.32%	70
2017 Q1	$3.91M	Buy	+60,000	New	+$3.77M	0.2%	112
2016 Q3	–	Sell	-122,010	Closed	-$7.55M	–	307
2016 Q2	$7.55M	Buy	+122,010	New	+$7.43M	0.31%	90
2015 Q3	–	Sell	-31,500	Closed	-$2.12M	–	261
2015 Q2	$2.12M	Buy	+31,500	New	+$2.06M	0.04%	192
2014 Q4	–	Sell	-586,500	Closed	-$33.9M	–	216
2014 Q3	$33.9M	Buy	586,500 +519,981	+782%	+$28.9M	1.27%	17
2014 Q2	$3.75M	Buy	66,519 +59,019	+787%	+$3.1M	0.14%	109
2014 Q1	$386K	Sell	7,500 -7,500	-50%	-$379K	0.02%	178
2013 Q4	$792K	Sell	15,000 -55,656	-79%	-$2.74M	0.04%	125
2013 Q3	$3.16M	Buy	70,656 +9,266	+15%	+$411K	0.2%	73
2013 Q2	$2.54M	Buy	+61,390	New	+$2.68M	0.19%	71

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Highland Capital Management (Texas)'s ABBV Position: Q2 2019 in Review

Highland Capital Management (Texas) increased its AbbVie (ABBV) stake by 200% in Q2 2019, buying an estimated $786K and bringing the position to 15,000 shares worth $1.09M. The position accounts for 0.06% of the portfolio, ranked #202.

Highland Capital Management (Texas) first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $33.9M in Q3 2014. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Highland Capital Management (Texas) held 15,000 shares of AbbVie worth $1.09M as of Q2 2019.
Highland Capital Management (Texas) bought 10,000 AbbVie shares in Q2 2019, an estimated $786K.
AbbVie made up 0.06% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #202 holding.
Highland Capital Management (Texas) first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Highland Capital Management (Texas)'s AbbVie position peaked at $33.9M in Q3 2014.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.